CLINICALLY MANAGED
HORMONES & HEALTH
Guideline-concordant testosterone evaluation, vascular and sexual medicine, urological diagnostics, and preventive health care delivered by clinicians who take the time to listen.
Evidence-Based Protocols • Longitudinal Biomarker Monitoring • Private Providence Facility
Clinical Specialties
Protocol-driven diagnostic evaluation and evidence-based management across endocrine, vascular, prostatic, and preventive men’s health.
01
Testosterone Testing & TTh Evaluation
Guideline-concordant evaluation of male hypogonadism utilizing confirmatory morning HPG-axis blood panels, bioavailable androgen fractions, and longitudinal safety monitoring.
Explore Endocrine Care
02
Erectile Dysfunction & Advanced Therapies
Multi-system vascular, endocrine, and structural workups featuring tiered oral pharmacotherapy, patient-specific ICI formulations, VED rehabilitation, and Peyronie’s care.
Explore Sexual Medicine
03
BPH & Lower Urinary Tract Evaluation
Comprehensive diagnostic assessment of lower urinary tract symptoms (LUTS), validated IPSS symptom scoring, PSA surveillance, and individualized medical management for benign prostatic hyperplasia.
Explore Prostate Care
04
Men’s Health Assessment & STI Diagnostics
Discreet, high-sensitivity molecular NAAT/PCR pathogen testing, 4th-generation viral serology, cardiometabolic risk profiling, and CDC-guided antimicrobial protocols.
Explore DiagnosticsWelcoming New Patients
Center for Men’s Health Rhode Island bridges the gap between rushed primary care visits and commercialized online subscription clinics—delivering specialist-led, in-person medical care in a private Providence setting.
Featured on The Rhode Show
Flexible Payment Options for
Evaluation & Management
Center for Men’s Health Rhode Island provides transparent pricing and clear billing pathways without high-pressure long-term contracts.
Commercial Insurance Accepted
If you choose to utilize insurance for clinical evaluations and diagnostic laboratory workups, our staff will verify your plan participation and assist with prior authorization requirements.
Direct Self-Pay Options
For patients who prefer enhanced billing privacy or are pursuing specialized non-covered modalities, we offer straightforward self-pay pricing with full upfront transparency.
Meet the Founders
Leonard Berkowitz, PA-C
As Co-Founder and Lead Clinician, Leonard Berkowitz brings over 17 years of specialized medical experience in hormone evaluation, urological wellness, and primary family care. He is dedicated to combining expert clinical diagnostics with sustainable, evidence-based strategies to help every patient achieve long-term health and vitality.
Jose Bolanos
Jose serves as Co-Founder and Chief Operating Officer at the Center for Men’s Health Rhode Island, supporting practice operations, patient education, and regulatory compliance frameworks. Leveraging a background in men’s health research and systems design, he focuses on translating complex clinical science into clear patient resources while implementing secure, HIPAA-compliant digital workflows.
View Google Scholar Profile
Your care
Your records
One secure portal
Use our encrypted eClinicalWorks and healow patient portal to manage appointments, review laboratory results, communicate directly with our clinical team, and access your medical records.
Clinical Practice Standards & Regulatory Transparency
Clinical evaluations and medical management at Center for Men’s Health Rhode Island are guided by peer-reviewed clinical practice guidelines from the American Urological Association (AUA), The Endocrine Society, and the Centers for Disease Control and Prevention (CDC). All prescription therapies—including Schedule III controlled substances and patient-specific 503A compounded preparations—require an in-person clinical evaluation, confirmatory diagnostic laboratory testing, and ongoing medical surveillance by a licensed healthcare provider.
Investigational & Compounding Notice: Low-intensity extracorporeal shockwave therapy (Li-ESWT / rESWT) is not FDA-cleared or FDA-approved for the treatment of erectile dysfunction, BPH, or Peyronie’s disease. Patient-specific compounded medications are prepared by independently licensed 503A compounding pharmacies and are not FDA-approved.